Reuters logo
BRIEF-Loxo Oncology reports quarterly loss per share of ‍$2.45
November 2, 2017 / 12:25 PM / 19 days ago

BRIEF-Loxo Oncology reports quarterly loss per share of ‍$2.45

Nov 2 (Reuters) - Loxo Oncology Inc:

* Loxo Oncology announces third quarter 2017 financial results

* Qtrly non-GAAP loss per share ‍$0.94

* ‍Larotrectinib New Drug Application (NDA) submission to U.S. FDA on track for year end 2017 / early 2018​

* Qtrly GAAP loss per share ‍$2.45​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below